Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Home (current)
  • Diseases
    Alzheimer's Disease
    Dementia
    Dementia with Lewy Bodies
    Frontotemporal Dementia
    Vascular Dementia
    Mild Cognitive Impairment
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Communication
    Treatment
    Care Practice
    Prevention
    View all Topics
  • Conferences
    ARUK 2023
    CTAD 2022
    AAIC 2022
    EAN 2022
    ESOC 2022
    AAN 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Alvaro Pascual-Leone

Lecanemab: drawbacks to consider 3:02
Lecanemab: drawbacks to consider
Alvaro Pascual-Leone • 9 Jan 2023
Lecanemab: a review 5:24
Lecanemab: a review
Alvaro Pascual-Leone • 9 Jan 2023
FDA approval of lecanemab: what does the data tell us about the amyloid hypothesis? 2:10
FDA approval of lecanemab: what does the data tell us about the amyloid hypothesis?
Alvaro Pascual-Leone • 9 Jan 2023
Lecanemab vs aducanumab 1:35
Lecanemab vs aducanumab
Alvaro Pascual-Leone • 9 Jan 2023
Primary care digital screening tool for Alzheimer’s disease 4:30
Primary care digital screening tool for Alzheimer’s disease
Alvaro Pascual-Leone • 9 Jan 2023
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy